CHARCOT-MARIE-TOOTH DISEASE TYPE-1A (CMT1A) PLUS

被引：0
|
作者：
Simmons, M. [1 ]
Tao, F. [2 ]
Abreu, L. [2 ]
Zuchner, S. [2 ]
Li, J. [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA
[2] Univ Miami, Hussman Inst Human Genom, Miami, FL USA
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2017年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [21] LINKAGE MAPPING OF CHARCOT MARIE TOOTH NEUROPATHY (CMT1A)
    NICHOLSON, GA
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 2008 - 2008
  • [22] Status of the pivotal phase III study of PXT3003 for Charcot-Marie-Tooth Type 1A disease (CMT1A)
    Goedkoop, Rene
    Attarian, Sharam
    Young, Peter
    Sevilla, Teresa
    Van Damme, Philip
    de Visser, Marianne
    Thomas, Florian
    Roberts, Mark
    Foucquier, Julie
    Boutalbi, Youcef
    Cohen, Daniel
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 319 - 319
  • [23] A global analysis of the CMT1A locus: implications for the origin and susceptibility to Charcot-Marie-Tooth disease type 1A across populations
    Rodriguez Cruz, P.
    Alitsiou, A.
    Diagne, R.
    Lia-Baldini, A.
    Ghorab, K.
    Diop, A. Gallo
    Ndiaye, M.
    Beltran, S.
    Lao, O.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [24] P2X7 RECEPTOR IMPLICATION IN CHARCOT-MARIE-TOOTH TYPE 1A (CMT1A)
    Nobbio, L.
    Visigalli, D.
    Mannino, E.
    Pareyson, D.
    Sereda, M. W.
    Prada, V
    Mancardi, G.
    Zocchi, E.
    Bruzzone, S.
    Schenone, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 : 80 - 80
  • [25] Charcot-Marie-Tooth disease: correction of the CMT-1A phenotype
    Davies, Shelley L.
    Moral, M. Angels
    DRUGS OF THE FUTURE, 2006, 31 (06) : 531 - 533
  • [26] PRENATAL-DIAGNOSIS OF CHARCOT-MARIE-TOOTH DISEASE TYPE 1A (CMT1A) USING MOLECULAR-GENETIC TECHNIQUES
    NAVON, R
    TIMMERMAN, V
    LOFGREN, A
    LIANG, P
    NELIS, E
    ZEITUNE, M
    Van Broeckhoven, C
    PRENATAL DIAGNOSIS, 1995, 15 (07) : 633 - 640
  • [27] Synergy of baclofen, naltrexone and sorbitol (PXT3003) in Charcot-Marie-Tooth Type 1A (CMT1A)
    Laffaire, Julien
    Rinaudo, Philippe
    Bertrand, Viviane
    Schmitt, Peter
    Goedkoop, Rene
    Cohen, Daniel
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 335 - 335
  • [28] Charcot-Marie-Tooth (CMT) disease: an update
    Vallat, Jean-Michel
    Funalot, Benoit
    M S-MEDECINE SCIENCES, 2010, 26 (10): : 842 - 847
  • [29] LOCALIZATION OF A LOCUS FOR CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-IA (CMT1A) TO CHROMOSOME-17
    MCALPINE, PJ
    FEASBY, TE
    HAHN, AF
    KOMARNICKI, L
    JAMES, S
    GUY, C
    DIXON, M
    QAYYUM, S
    WRIGHT, J
    COOPLAND, G
    LEWIS, M
    KAITA, H
    PHILIPPS, S
    WONG, P
    KOOPMAN, W
    COX, DW
    YEE, WC
    GENOMICS, 1990, 7 (03) : 408 - 415
  • [30] CHARCOT-MARIE-TOOTH DISEASE TYPE-1
    MALCOLM, S
    JOURNAL OF MEDICAL GENETICS, 1992, 29 (01) : 3 - 4
12345